Endogenous levels of testosterone and sex hormone-binding globulin (SHBG) were inversely associated with the risk of developing CRC in men [10]; similarly there seems to be an inverse relationship between endogenous oestradiol or SHBG levels and CRC risk in postmenopausal women [11]. This evidence concerns the gene SHBG and colorectal carcinoma.